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Acetylcholine in the brain alters neuronal excitability, influences synaptic transmission, induces synaptic
plasticity, and coordinates firing of groups of neurons. As a result, it changes the state of neuronal networks
throughout the brain andmodifies their response to internal and external inputs: the classical role of a neuro-
modulator. Here, we identify actions of cholinergic signaling on cellular and synaptic properties of neurons in
several brain areas and discuss consequences of this signaling on behaviors related to drug abuse, attention,
food intake, and affect. The diverse effects of acetylcholine depend on site of release, receptor subtypes, and
target neuronal population; however, a common theme is that acetylcholine potentiates behaviors that are
adaptive to environmental stimuli and decreases responses to ongoing stimuli that do not require immediate
action. The ability of acetylcholine to coordinate the response of neuronal networks in many brain areas
makes cholinergic modulation an essential mechanism underlying complex behaviors.Acetylcholine (ACh) is a fast-acting, point-to-point neurotrans-
mitter at the neuromuscular junction and in the autonomic
ganglia; however, there are fewer demonstrations of similar
actions in the brain (Changeux, 2010). Instead, central cholin-
ergic neurotransmission predominantly changes neuronal excit-
ability, alters presynaptic release of neurotransmitters, and coor-
dinates the firing of groups of neurons (Kawai et al., 2007; Rice
and Cragg, 2004; Wonnacott, 1997; Zhang and Sulzer, 2004).
As a result, ACh appears to act as a neuromodulator in the brain,
despite its role as the primary excitatory neurotransmitter in the
periphery.
The definition of a neuromodulator is flexible, but has evolved
to describe any kind of neurotransmission that is not directly
excitatory (mediated through ionotropic glutamate receptors)
or inhibitory (mediated through ionotropic gamma-aminobutyric
acid [GABA] receptors) (Ito and Schuman, 2008; Siggins, 1979).
Neuromodulation can be thought of as a change in the state of
a neuron or group of neurons that alters its response to sub-
sequent stimulation. A number of models have been proposed
to explain the actions of ACh in the central nervous system
(CNS). For example, ACh has been suggested to be critical for
the response to uncertainty, such that an increase in cholinergic
tone predicts the unreliability of predictive cues in a known
context and improves the signal-to-noise ratio in a learning envi-
ronment (Yu and Dayan, 2005). Another model has suggested
that ACh reinforces neuronal loops and cortical dynamics during
learning by enhancing the influence of feed-forward afferent
inputs to the cortex carrying sensory information and decreas-
ing excitatory feedback activity mediating retrieval (Hasselmo,
2006). ACh can also alter firing of neurons on a rapid time scale,
as in fear-conditioning, when foot-shock results in direct cholin-116 Neuron 76, October 4, 2012 ª2012 Elsevier Inc.ergic activation of interneurons in the auditory cortex that con-
tribute to learning (Letzkus et al., 2011). All these models are
consistent with a primary role of ACh as a neuromodulator that
changes the state of an ensemble of neurons in response to
changing environmental conditions.
In this review, we will provide further support for the idea that
cholinergic neurotransmission in the brain is primarily neuromo-
dulatory and is categorically distinct from the actions of ACh at
the neuromuscular junction. We propose that the role of ACh
as a neuromodulator in the brain is to increase neurotransmitter
release in response to other inputs, to promote burst firing, and/
or suppress tonic firing, depending upon the system and the
neuronal subtypes stimulated. Further, ACh contributes to syn-
aptic plasticity in many brain areas.
Cholinergic Neurons and Ach Receptors
The two primary sources of ACh in the brain include projection
neurons that innervate distal areas and local interneurons that
are interspersed among their cellular targets. Cholinergic projec-
tion neurons are found in nuclei throughout the brain, such as
the pedunculopontine and laterodorsal tegmental areas (PPTg
and LDTg), the medial habenula (MHb) (Ren et al., 2011), and
the basal forebrain (BF) complex (Mesulam, 1995; Zaborszky,
2002; Zaborszky et al., 2008), including the medial septum.
These cholinergic neurons project widely and diffusely, inner-
vating neurons throughout the CNS. Cholinergic interneurons
are typified by the tonically active ACh neurons of the striatum
and nucleus accumbens, and there is some indication from
anatomical studies that cholinergic interneurons are present in
the rodent and human neocortex, but not the nonhuman primate
cortex (Benagiano et al., 2003; Mesulam, 1995; von Engelhardt
Figure 1. Sites of Action for Nicotinic and
Muscarinic Acetylcholine Receptors
Nicotinic (nAChR) and muscarinic (mAChR)
acetylcholine receptors are localized both pre- and
postsynaptically. Presynaptic mAChRs (M2, M4)
are largely inhibitory and act as inhibitory autor-
eceptors on cholinergic terminals, with M2 the
predominant autoreceptor in the hippocampus
and cerebral cortex and M4 predominant in
striatum (Wess, 2003b; Wess et al., 2003). Post-
synaptic mAChRs can be either inhibitory (M2, M4)
or excitatory (M1, M3, M5) (Wess, 2003b; Wess
et al., 2003). Presynaptic nAChRs induce release
of a number of neurotransmitters, including GABA,
glutamate, dopamine, serotonin, norepinephrine,
and acetylcholine (McGehee et al., 1995; Wonna-
cott, 1997). Postsynaptic nAChRs depolarize
neurons, increase their firing rate, and can con-
tribute to long-term potentiation (Bucher and
Goaillard, 2011; Ge and Dani, 2005; Ji et al., 2001;
Kawai et al., 2007; Mansvelder and McGehee,
2000; Picciotto et al., 1995, 1998; Radcliffe and
Dani, 1998; Wooltorton et al., 2003).
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of cholinergic cells are mediated through pre- and postsynaptic
receptors on a large variety of neuronal subtypes throughout the
brain, and it should be noted that cholinergic inputs contribute to
cortical and hippocampal function across phylogeny.
ACh signals through two classes of receptors: metabotropic
muscarinic receptors (mAChRs) and ionotropic nicotinic recep-
tors (nAChRs) (reviewed in Picciotto et al., 2000 and Wess,
2003a). Muscarinic receptors are coupled either to Gq proteins
(M1, M3, and M5 subtypes) that activate phospholipase C or
Gi/o proteins (M2 and M4 subtypes) that negatively couple to ad-
enylate cyclase (reviewed inWess, 2003a), linking ACh activity to
a variety of biochemical signaling cascades. Moreover, mAChRs
are located both pre- and postsynaptically throughout the brain,
producing diverse consequences for brain activity (Figure 1). As
examples of the heterogeneous effects of mAChR stimulation,
presynaptic M2/M4mAChRs can act as inhibitory autoreceptors
on cholinergic terminals (Douglas et al., 2002; Raiteri et al., 1984)
and reduce glutamate release from corticocortical and cortico-
striatal synapses (Higley et al., 2009, Gil et al., 1997). In contrast,
M1/M5 receptors can stimulate dopamine (DA) release from
striatal synaptosomes (Zhang et al., 2002) and postsynaptic
M1/M5 receptors can increase excitability of cortical pyramidal
neurons (Douglas et al., 2002; McCormick and Prince, 1985).
Nicotinic receptors function as nonselective, excitatory cation
channels (Changeux et al., 1998; Picciotto et al., 2001) and occur
as homomeric or heteromeric assemblies of a large family of a-
and b-subunits (a2-a7 and b2-b4; reviewed in Picciotto et al.,
2000). While neuromodulators are typically associated with
metabotropic signaling, the role of the ionotropic nAChRs in
the brain appears to be largely modulatory as well (Picciotto,
2003). For example, nAChRs are not clustered at postsynaptic
membranes apposed to sites of ACh release, but are rather
dispersed along the surface (and intracellular compartments)
of neurons, including presynaptic terminals (McGehee et al.,
1995; Vidal and Changeux, 1993), cell bodies, and even axons
(Arroyo-Jime´nez et al., 1999; Hill et al., 1993; Kawai et al.,
2007). In addition, stimulation of nAChRs can increase the
release of glutamate, GABA, DA, ACh, norepinephrine, and sero-tonin (McGehee et al., 1995; Wonnacott, 1997) (Figure 1). Nico-
tinic modulation of neurotransmitter release is often subtype-
specific, and this specificity can vary across brain areas, with
distinct nAChRs coupling to release of glutamate (a7) versus
GABA (a4b2) (Mansvelder et al., 2002) in the ventral tegmental
area (VTA), while b2-containing nAChRs can modulate the
release of glutamate from thalamocortical projections (Parikh
et al., 2010). Similarly, different nAChR subtypes mediate the
release of DA (a4/a6b2) versus ACh (a3b4) (Grady et al., 2001).
Presynaptic effects of nAChRs contribute to synaptic plasticity
in the VTA (Mansvelder and McGehee, 2000; Wooltorton et al.,
2003), hippocampus (Ge and Dani, 2005; Ji et al., 2001; Radcliffe
and Dani, 1998), and prefrontal cortex (Couey et al., 2007). In
addition, nAChRs may also be important for synchronizing
neuronal activity. For example, nicotine is reported to coordinate
firing of thalamocortical fibers through effects on nAChRs in
white matter (Bucher and Goaillard, 2011; Kawai et al., 2007).
Despite the clear effects of presynaptic nAChRs in electro-
physiological studies, their relationship to the behavioral
consequences of nicotine administration is not completely
understood. For example, nicotine stimulates the firing of DA
neurons through actions in the VTA and increases release of
DA from the midbrain projections to the nucleus accumbens
(NAc) through actions on terminal nAChRs, but local infusion of
nicotine into the VTA has much greater effects on locomotion
and self-administration than local infusion into the NAc (Ferrari
et al., 2002; Ikemoto et al., 2006). Recent studies have, however,
suggested that nAChRs in the NAc are important for the motiva-
tional effects of nicotine (association between stimulus and drug
intake), rather than the primary reinforcing effects of the drug
(desire for drug) (Brunzell et al., 2010). In addition, it is clear
that cholinergic interneurons and their regulation of muscarinic
receptor signaling are also critical components in striatum-
dependent decision making (see, e.g., Goldberg et al., 2012).
While presynaptic effects of nAChRs have been the focus of
a great deal of work, effects of nicotinic stimulation are clearly
not exclusively presynaptic (Figure 1). Exogenous application
of nicotine can induce significant inward currents in neurons in
a number of brain areas (Le´na and Changeux, 1999; PicciottoNeuron 76, October 4, 2012 ª2012 Elsevier Inc. 117
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direct postsynaptic effects of ACh in the brain (Alkondon et al.,
1998; Jones et al., 1999). Notably, recent studies using optoge-
netic techniques demonstrated that ACh can mediate postsyn-
aptic responses through nAChRs in the hippocampus (Bell
et al., 2011; Gu and Yakel, 2011) and cortex (Arroyo et al., 2012).
Modes of Cholinergic Neuromodulation
Although there is considerable evidence for the actions of ACh
on target neurons, the mode of cholinergic transmission has
remained controversial. The debate has focused on whether
cholinergic signaling occurs via traditional synapses (cellular
specializations comprising closely apposed pre- and postsyn-
aptic membranes with associated release/receptor machinery)
or via volume transmission (actions of a neurotransmitter that
occur at a distance from its site of release, mediated by diffusion
through the extracellular space (Zoli et al., 1999). Accumulating
evidence indicates that ACh can act through volume transmis-
sion in the brain. The relatively diffuse nature of brain cholinergic
innervation further reinforces this idea. There is an anatomical
mismatch between the sites of ACh release (Houser, 1990;
Wainer et al., 1984a, 1984b) and the location of cholinergic
receptors (Arroyo-Jime´nez et al., 1999; Hill et al., 1993; Kawai
et al., 2007). There is also evidence that extracellular levels of
ACh fluctuate in a manner that is not consistent with localized
clearance of a synaptic transmitter (Hajnal et al., 1998; Laplante
et al., 2004; Mark et al., 1996; Parikh et al., 2004; Reid et al.,
1998). However, contrasting observations, including the role of
ACh in fast synaptic transmission at the neuromuscular junction
and the high level of expression of ACh esterase (AChE; a highly
efficient degradative enzyme responsible for clearing ACh from
the extracellular space) have limited the acceptance of this
idea. Ultimately, it is difficult to know how far ACh can diffuse
from its site of release and whether volume transmission would
allow for rapid transfer of information, suggesting that this is
not the only mechanism through which ACh influences neuronal
function in the brain. Anatomical studies have identified cortical
cholinergic synapses that are structurally similar to those of other
point-to-point neurotransmitters in both rats (Turrini et al., 2001)
and humans (Smiley et al., 1997). Effects of ACh on a rapid time-
scale likely underlie its role in stimulus-response tasks in which
subsecond reactivity is required for appropriate behavioral re-
sponses, as in prefrontal cortex-dependent cue detection (Par-
ikh et al., 2007a) or auditory discrimination (Letzkus et al.,
2011). The data indicate that differences in sites of receptor
expression, affinity of ACh at both mAChRs and nAChRs, rates
of synaptic clearance by [AChE]) and local concentration of
ACh in and outside the synapse are critical for the control and
specificity of cholinergic signaling. In addition, differences in
the time-scale of release at the local microcircuit level further
refine the action of ACh in complex behaviors (reviewed in Has-
selmo and Giocomo, 2006; Sarter et al., 2009; and Yu and
Dayan, 2005).
Role of Ach in Synaptic Plasticity and Neuronal
Development
An important role for both nAChRs and mAChRs has been
defined in hippocampal synaptic plasticity (reviewed in Giocomo118 Neuron 76, October 4, 2012 ª2012 Elsevier Inc.and Hasselmo, 2007 and McKay et al., 2007), and these effects
are mediated through intracellular signaling pathways down-
stream of mAChRs and nAChRs (reviewed in Berg and Conroy,
2002; Cancela, 2001; Lanzafame et al., 2003; and Rathouz
et al., 1996). Recent studies suggest that the timing of ACh
release and the subtype of receptor is critical for the type of plas-
ticity induced (Gu and Yakel, 2011); however, it is clear that
nAChRs and mAChRs on both GABAergic and glutamatergic
neurons in the hippocampus can alter the subsequent response
to excitatory inputs (Drever et al., 2011). Similarly, stimulation of
nAChRs on glutamatergic terminals in the VTA can induce long-
term potentiation (LTP) of excitatory inputs onto DA neurons
(Mansvelder and McGehee, 2000), whereas differential time-
scales of effects of nAChRs on glutamatergic and GABAergic
terminals in this area appears to be important for changes in
dopaminergic firing following prolonged exposure to nicotine
(Mansvelder et al., 2002; Wooltorton et al., 2003).
The ability of ACh to influence synaptic plasticity and dy-
namics of local circuits can also occur through astrocytic control
of synaptic Ca2+ concentration following nAChR stimulation (Ta-
kata et al., 2011). Astrocytic signaling can lead to LTP as a result
of the temporal coincidence of the postsynaptic activity and the
astrocyte Ca2+ signal simultaneously evoked by cholinergic
stimulation (Navarrete et al., 2012).
In contrast to the ability of nAChR stimulation to promote LTP
in a number of brain areas, nAChR-mediated facilitation of GABA
release reduces calcium levels in prefrontocortical dendrites
(Couey et al., 2007). In addition, activation of nAChRs can also
decrease subsequent stimulation of calcium entry into cortical
neurons in response to glutamate (Stevens et al., 2003). The
decrease in glutamate-mediated calcium entry is mediated
through activation of high affinity nAChRs, subsequent activation
of the protein phosphatase calcineurin, and inactivation of
L-type calcium channels. If this mechanism is also recruited as
a result of ACh signaling in vivo, it would suggest that one conse-
quence of cholinergic activity in cortical neurons would be a
significant decrease in subsequent calcium-mediated glutamate
responses.
Finally, in addition to the ability of ACh to modulate neuronal
activity acutely in adulthood, ACh can also alter a number of
processes in neuronal development, and the molecular basis
for a number of these developmental effects of ACh signaling
have been elucidated recently. For example, one fundamental
role for ACh signaling through nAChRs is to regulate the timing
of expression of the chloride transporter that is necessary for
the ability of GABA to hyperpolarize, and therefore inhibit, central
neurons (Liu et al., 2006). Disrupting nAChR signaling delays the
switch from GABA-mediated excitation to inhibition. Recent
studies have also shown that nAChRs contribute to the matura-
tion of GABAergic (Kawai et al., 2002; Zago et al., 2006) and glu-
tamatergic (Lozada et al., 2012a, b) synapses, highlighting an
important role for ACh signaling in synaptic development, as
well as neuronal pathfinding and target selection (reviewed in
Role and Berg, 1996). In addition, signaling through nAChRs is
also important for establishing critical periods for activity-depen-
dent shaping of visual cortical function (Morishita et al., 2010)
and maturation of thalamocortical (Aramakis and Metherate,
1998; Aramakis et al., 2000; Hsieh et al., 2002) and
Figure 2. Effects of Acetylcholine on Activity of Dopamine Neurons
in the Mesolimbic Circuit
Salient cues associated with primary reward increase activity of PPTg
neurons, inducing acetylcholine release in the VTA (Futami et al., 1995;
Omelchenko and Sesack, 2006). Acetylcholine increases firing of DA neurons
in the VTA and is likely to be important for burst firing of these neurons
(Maskos, 2008). Salient cues associated with reward also induce a pause in
firing of tonically active cholinergic neurons in the NAc (Goldberg and Rey-
nolds, 2011). Decreased release of ACh onto terminals in NAc attenuates DA
release due to tonic firing of DA neurons, while preserving DA release in
response to phasic firing (Exley and Cragg, 2008).
Neuron
Reviewcorticothalamic (Heath et al., 2010; Horst et al., 2012; King et al.,
2003; Picciotto et al., 1995) glutamatergic synapses. It appears
likely that ACh release, potentially in response to salient stimuli,
potentiates glutamatergic synapses during development
through an LTP-like mechanism (Aramakis and Metherate,
1998), highlighting another important role for cholinergic
signaling in synaptic plasticity. Several neurotrophic factors are
also involved in the development and maturation of cholinergic
neurons, but the dependence on neurotrophins is not homoge-
nous throughout the CNS (for reviews, see Angelucci et al.,
2005 and Schindowski et al., 2008). Although a comprehensive
review of the developmental effects of ACh is beyond the scope
of this article, it is important to note that various developmental
processes can be affected by ACh signaling (for more compre-
hensive reviews, see Heath and Picciotto, 2009; Liu et al.,
2007; Metherate and Hsieh, 2003; and Role and Berg, 1996).
Brain Systems Modulated by Ach Signaling
Mesolimbic DA System, Addiction and Reward
A great deal of research has focused on the effects of cholinergic
agents on the mesolimbic DA system and its short- and long-
term modulation (for reviews, see Fagen et al., 2003; and Man-
svelder et al., 2003), particularly because the addictive effects
of nicotine are mediated primarily through stimulation of nAChRs
in the VTA (Drenan et al., 2008;Maskos et al., 2005; McGranahan
et al., 2011; Picciotto et al., 1998). Cholinergic input from the
PPTg and LDTg acting through both mAChRs and nAChRs is
critical for modulating the function of the VTA. Stimulation of
nAChRs and M5-type mAChRs increases the tonic excitability
of these DA neurons (Corrigall et al., 2002; Miller and Blaha,
2005; Yeomans and Baptista, 1997). ACh released in the VTA
would potentiate glutamatergic synaptic transmission onto DA
neurons through a7 nAChRs and therefore increase the likeli-
hood of burst firing of these neurons (Grenhoff et al., 1986; Mas-
kos, 2008; McGehee et al., 1995).
Extracellular ACh levels are increased in the VTA during drug
self-administration (You et al., 2008), which could result from
an increase in ACh release from PPTgg and LDTg afferents (Fu-
tami et al., 1995; Omelchenko and Sesack, 2006). Cholinergic
neurons within PPT do not exhibit burst firing, and they are
more active during wakefulness and rapid eye movement
(REM) sleep versus slow wave sleep (Datta and Siwek, 2002);
however, there is currently no evidence that VTA DA neurons
show circadian variations in activity, suggesting that the diurnally
regulated neurons may not project to VTA. In addition, PPTg
neurons change their firing rate in response to both locomotion
and acquisition of reward (Datta and Siwek, 2002). These obser-
vations have led to the idea that the PPTg acts as a gate for
salient sensory information associated with reward and/or
requiring movement (Norton et al., 2011).
In contrast to the increased firing rate of cholinergic neurons in
the PPTg in response to contextual information related to
reward, tonically active cholinergic interneurons in the striatum
pause their firing following exposure to cues associated with
reward (Goldberg and Reynolds, 2011). The pause is thought
to be mediated by interactions between the cells’ intrinsic
membrane properties and strong feed-forward excitation from
the thalamus (Ding et al., 2010). These cholinergic interneuronscan regulate the duration, magnitude, and spatial pattern of
activity of striatal neurons, potentially creating an attentional
gate that facilitates movement toward salient stimuli (Oldenburg
and Ding, 2011). The function of striatal cholinergic interneurons
is also impaired in patients with movement disorders involve the
dopaminergic system, such as Parkinson’s and Huntington’s
disease and in animal models of these diseases (Ding et al.,
2011). Cholinergic signaling in striatum and NAc is also thought
to be critical for mediating the association between drugs of
abuse and cues in the environment that drive drug craving and
relapse to drug use after abstinence (Exley and Cragg, 2008).
The effects of striatal ACh aremediated in part through activation
of nAChRs on dopaminergic terminals, leading to tonic, low level
DA release when cholinergic interneurons are firing. The pause
results in decreased tonic DA release, but maintained phasic
DA release (Exley andCragg, 2008). In contrast, mAChRs reduce
the probability of glutamate release from excitatory afferents to
the striatum, negatively regulating the ability of these inputs to
drive striatal activity (Barral et al., 1999; Higley et al., 2009; Pak-
hotin and Bracci, 2007). Reduced concentration of glutamate in
the synaptic cleft results in diminished activation of voltage-
dependent N-methyl-D-aspartate (NMDA)-type glutamate recep-
tors, shortening excitatory response duration and limiting
temporal integration of inputs (Higley et al. 2009). Thus, the
pause in cholinergic interneuron firing would be predicted to
enhance the efficacy and summation of glutamatergic inputs
arriving during this period.
These findings suggest that salient sensory stimuli in the
environment, such as those associated with reward or drugs
of abuse, would increase activity of PPTg cholinergic neurons,
leading to increased phasic firing of DA neurons in the VTA (Mas-
kos, 2008), while at the same time decreasing the firing of toni-
cally active cholinergic neurons in the NAc and striatum, leading
to a larger differential in DA release in response to phasic firing as
compared to tonic firing (Exley andCragg, 2008) (Figure 2). At the
behavioral level, this conclusion is consistent with the findingNeuron 76, October 4, 2012 ª2012 Elsevier Inc. 119
Figure 3. Effects of Acetylcholine on Activity of Cortical Neurons
Salient cues induce acetylcholine release onto interneurons targeting the
apical dendrites of cortical pyramidal neurons, resulting in rapid inhibition
of pyramidal cells (Arroyo et al., 2012; Couey et al., 2007; Fanselow et al.,
2008; Fe´re´zou et al., 2002; Gulledge et al., 2007; Kawaguchi and Kubota,
1997). Acetylcholine subsequently depolarizes pyramidal neurons through M1
mAChRs (Delmas and Brown, 2005; McCormick and Prince, 1985, 1986).
Acetylcholine also activates stimulatory a4b2 nAChRs on glutamatergic tha-
lamocortical terminals (Gil et al., 1997; Lambe et al., 2003; Oldford and Castro-
Alamancos, 2003) and inhibitory M2 mAChRs on GABAergic terminals of
parvalbumin-expressing (PV) interneurons (Kruglikov and Rudy, 2008). Acti-
vation of PV interneurons enhances stimulation of pyramidal neuron firing by
thalamocortical inputs (Gabernet et al., 2005; Higley and Contreras, 2006;
Kruglikov and Rudy, 2008). Acetylcholine also suppresses corticocortical
transmission through inhibitory M2 mAChRs on pyramidal cell axon terminals
(Gil et al., 1997; Hsieh et al., 2000; Kimura and Baughman, 1997; Oldford and
Castro-Alamancos, 2003), reducing intracortical communication while pre-
serving responses to thalamic inputs (Kimura et al., 1999).
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locomotor effects of drugs of abuse, such as cocaine and nico-
tine (Champtiaux et al., 2006; Corrigall et al., 1994, 2002), while
lesion of NAc cholinergic neurons increases cocaine self-admin-
istration, as might be expected if a pause in cholinergic inter-
neuron firing in NAc signals salience (Smith et al., 2004).
The behavioral role of individual ACh receptor subtypes in NAc
ismore complex, however. Consistent with a role for the pause in
NAc cholinergic neurons in behaviors related to drug reward,
antagonism of a7-type nAChRs in NAc increases motivation to
lever press for nicotine (Brunzell and McIntosh, 2012). Less intu-
itively, blockade of mAChRs using scopolamine decreases rein-
statement of cocaine seeking (Yee et al., 2011), but this may be
due to increased ACh release through blockade of inhibitory
autoreceptors (Douglas et al., 2001). Consistent with the fact
that neuromodulation can be complex, it has also been shown
that antagonism of the a6/b2 class of nAChRs expressed on
DA terminals in NAc decreases the breakpoint for progressive
ratio responding in rats self-administering nicotine, suggesting
that there is also a role for ACh signaling through this class of
receptors for mediating the motivational value of nicotine (Brun-
zell et al., 2010).
A number of studies have focused on the ability of the habe-
nula, particularly the MHb, to oppose the behavioral processes
mediated through the VTA (for reviews, see Fowler and Kenny,
2012 and Hikosaka, 2010). The MHb-interpeduncular pathway
is cholinergic, and it has been proposed that its effects on VTA
neuron firing are mediated indirectly through inhibition of the
PPTg (Maskos, 2008). Decreasing the expression of nAChRs
containing the a5 subunit in theMHb results in increased nicotine
self-administration (Fowler et al., 2011), suggesting that this
cholinergic system normally acts as a brake on drug reward.
Taken together, these studies suggest that point-to-point ACh
signaling could have opposing behavioral consequences, de-
pendingonthe receptorsubtypes,neuronalpopulations,andbrain
areas stimulated, and that effects of ACh mediated through vol-
ume transmission could be distinct from those mediated locally.
Cortex and Attention
Numerous studies indicate that ACh plays an important role in
the regulation of cortical activity over multiple timescales. The
precise function of ACh on any given circuit also depends on
the specific expression pattern of nAChRs and mAChRs, as
well as the temporal dynamics of ACh concentration in the extra-
cellular space. Neocortical ACh function has been linked to
control of circuits underlying attention, cue detection, and
memory (Hasselmo and Sarter, 2011). The primary cholinergic
input to the cerebral cortex comes from the BF complex
including the substantia innominata the nucleus basalis of Mey-
nert (Mesulam, 1995), though the latter remains debated (Za-
borszky et al., 1999). Cholinergic terminals are distributed
throughout the cortex, with more dense projections in superficial
layers (Mesulam, 1995).
The cellular mechanisms underlying the effects of ACh on
cortical circuits have been investigated at many levels. Seminal
studies revealed that ACh can produce biphasic changes in
the activity of pyramidal neurons, the principal excitatory cells
in the neocortex, comprising fast inhibition followed by a slow
depolarization (McCormick and Prince, 1985, 1986). The fast120 Neuron 76, October 4, 2012 ª2012 Elsevier Inc.inhibition is at least partially mediated by the actions of both
nAChRs and mAChRs that increase the excitability and firing
rates of dendrite-targeting GABAergic interneurons (Arroyo
et al., 2012; Couey et al., 2007; Fanselow et al., 2008; Fe´re´zou
et al., 2002; Gulledge et al., 2007; Kawaguchi and Kubota,
1997). The slow depolarization is mediated by M1 mAChR-
mediated closure of M-type (KCNQ) potassium channels in
pyramidal neurons (Delmas and Brown, 2005), enhancing their
excitability and reducing their spike frequency adaptation (Gul-
ledge et al., 2007; Hasselmo and Giocomo, 2006). In addition,
nAChRs expressed in deep layer pyramidal neurons may con-
tribute to direct excitation of these cells (Bailey et al., 2010; Kas-
sam et al., 2008; Poorthuis et al., 2012).
ACh also modulates synaptic transmission in cortical circuits
(Figure 3). Activation of a4b2 nAChRs on thalamocortical termi-
nals enhances glutamate release in both sensory and associa-
tion cortex (Gil et al., 1997; Lambe et al., 2003; Oldford and
Castro-Alamancos, 2003), whereas activation of mAChRs on
terminals of parvalbumin-expressing interneurons decreases
the probability of GABA release onto the perisynaptic compart-
ment of pyramidal neurons and therefore reduces postsynap-
tic inhibition of pyramidal neurons (Kruglikov and Rudy, 2008).
These interneurons normally decrease the response of cortical
neurons to feed-forward excitation (Gabernet et al., 2005; Higley
and Contreras, 2006), and the reduction of GABA release from
these interneurons by ACh therefore enhances the ability of
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glikov and Rudy, 2008).
In contrast, mAChRs located on pyramidal cell axon terminals
suppress corticocortical transmission (Gil et al., 1997; Hsieh
et al., 2000; Kimura and Baughman, 1997; Oldford and Castro-
Alamancos, 2003). Moreover, the ACh-mediated increased ex-
citability of dendrite-targeting interneurons described above
likely contributes to reduced efficacy of intracortical communi-
cation. The simultaneous enhancement of feed-forward inputs
from the thalamus through cholinergic actions on parvalbumin-
positive interneurons and suppression of intracortical feedback
inputs through effects on dendrite-targeting interneurons may
increase the ‘‘signal-to-noise’’ ratio in cortical networks, making
neurons more sensitive to external stimuli. In keeping with this
view, mAChR activation strongly suppresses the spread of intra-
cortical activity, leaving responses to thalamic inputs relatively
intact (Kimura et al., 1999). Intriguingly, in the prefrontal cortex,
the expression of nAChRs in deep pyramidal cells may produce
layer-specific cholinergic modulation, selectively enhancing
activity of output neurons (Poorthuis et al., 2012).
Although the cellular and synaptic effects of ACh described
above provide a potential mechanism for the ability of ACh to
increase signal detection and modulate sensory attention, a
number of observations suggest that this simple model is incom-
plete. ACh, acting via M4mAChRs, directly inhibits spiny stellate
cells in somatosensory cortex receiving thalamic input (Egger-
mann and Feldmeyer, 2009). Furthermore, activation of M1
mAChRs hyperpolarizes pyramidal neurons via a mechanism
dependent on fully loaded internal calcium stores that occurs
more quickly than the closure of M-type potassium channels
(Gulledge et al., 2007; Gulledge and Stuart, 2005). Thus, the
effect of ACh on the activity of pyramidal neurons depends crit-
ically on the state of the neuron and the timing of ACh release.
Neurons with depleted calcium stores would be more suscep-
tible to indirect ACh-induced depolarization via M4 mAChRs,
whereas rapid, direct inhibitory effects of ACh through M1
mAChRs would dominate in neurons with fully replenished
stores. Furthermore, studies showing that mAChR activation
reduces cortico-cortical transmission have relied on electrical
stimulation to evoke glutamate release, leaving the identity of
the activated presynaptic terminals ambiguous. It is possible
that distinct populations of intracortical synapses, such as those
comprising local recurrent networks versus long-range intra-
areal projections, might be differentially modulated by ACh.
Indeed, in the CA1 region of the hippocampus, long-range perfo-
rant inputs from the entorhinal cortex are less inhibited by ACh
than the Schaeffer collaterals arising from CA3 (Hasselmo and
Schnell, 1994). The advent of optogenetic tools for selectively
targeted difference populations of excitatory inputs (Gradinaru
et al., 2007) will be a key development for elucidating the precise
role of ACh on various circuit elements.
ACh also modulates cortical circuits over longer time scales
by influencing neuronal plasticity. In the auditory cortex, pairing
sensory stimulation with stimulation of the basal forebrain results
in long-term reorganization of cortical receptive field structure,
including a persistent shift in the receptive field toward the paired
stimulus (Froemke et al., 2007). In the visual system, ACh facili-
tates ocular dominance plasticity in kittens via M1 mAChRs(Gu and Singer, 1993), and in rodents, the protein Lynx1
suppresses nicotinic signaling in primary visual cortex, and its
removal promotes ocular dominance plasticity in older animals
(Morishita et al., 2010).
At the cellular level, cholinergic agonists enhance LTP of glu-
tamatergic association fibers in the piriform cortex and Schaeffer
collaterals in theCA1 region of the hippocampus (Huerta and Lis-
man, 1993). In contrast, M3mAChRs facilitate long-term depres-
sion of synapses in the monocular area of the superficial visual
cortex (Kirkwood et al., 1999; McCoy and McMahon, 2007).
Surprisingly, the same authors observed enhanced LTP in the
binocular cortex (McCoy et al., 2008). These regional differences
indicate that cell-type specific expression of different receptor
subtypes is critical for the varied actions of ACh.
The pleiotropic effects of ACh on cortical circuits described
above are likely to underlie its ability to modulate cognitive
behaviors. In rodents, lesions of cholinergic inputs to the cortex
impair tests of sustained attention, particularly across sensory
modalities (McGaughy et al., 1996, 2002; Turchi and Sarter,
1997). In addition, stimulation of a4b2 nAChRs in the medial
prefrontal cortex enhances performance in a visual attention
task (Howe et al., 2010), while genetic deletion of these receptors
in the medial PFC impairs visual attention (Guillem et al., 2011)
and auditory discrimination (Horst et al., 2012). Notably, transient
rises in prefrontal ACh are significantly correlated with cue
detection, suggesting that the temporal dynamics of cholinergic
signaling are also critical for normal behavior (Parikh et al.,
2007b). In primates, locally applied ACh enhances the attentional
modulation of neuronal activity in the primary visual cortex, while
the muscarinic antagonist scopolamine reduces the effects of
attention (Herrero et al., 2008). Taken together, these findings
suggest that cholinergic actions across both ionotropic and me-
tabotropic receptors and diverse brain areas contribute to cogni-
tive processing.
Hypothalamus and Food Intake
The role of ACh in control of autonomic functions is well known,
but it is likely that actions of ACh in the brain alsomodulate adap-
tive responses to environmental and metabolic conditions.
Cholinergic signaling can alter thermoregulation (Myers andWal-
ler, 1973), sleep patterns (Steriade, 2004), food intake (Grunberg
et al., 1988; Mineur et al., 2011), and endocrine functions, such
as pancreatic release of insulin and glucagon (Ishikawa et al.,
1982). The hypothalamus is essential for homeostatic responses
regulating metabolism, and consequently, modulation of hypo-
thalamic function by ACh is likely to be an important component
of adaptation to peripheral autonomic signals to the brain.
A small number of studies have investigated the role of ACh
signaling in the hypothalamus, which receives input from the
PPTg and LDTg (Hallanger and Wainer, 1988; Jones and Beau-
det, 1987). Activity in both these areas adapts quickly to environ-
mental changes (Majkutewicz et al., 2010; Woolf, 1991) and is
linked to peripheral control of feeding behavior (Phillis, 2005).
There are also intrinsic neurons within the hypothalamus that
express cholinergic markers (Tago et al., 1987) along with the
pro-opiomelanocortin (POMC) peptide (Meister et al., 2006),
and nAChRs in the hypothalamus are critical for feeding behavior
(Jo et al., 2002). It has also been suggested that neurons in the
median eminence could project to the hypothalamus (Scha¨ferNeuron 76, October 4, 2012 ª2012 Elsevier Inc. 121
Figure 4. Effects of Acetylcholine onHippocampal-Amygdala Stress
Response
Stress increases acetylcholine release in the hippocampus and frontal cortex
(Mark et al., 1996) and impairs signaling in the PFC (Arnsten, 2009). The
hippocampus provides inhibitory feedback to the amygdala through inhibition
of the HPA axis (Tasker and Herman, 2011), whereas the PFC can normally
decrease basolateral amygdala activity through projections to the intercalated
nucleus (Manko et al., 2011; Pinard et al., 2012). The effects of stress-induced
acetylcholine release on output of the hippocampus and cortex is unknown,
but cholinergic modulation of cortico-amygdala glutamatergic connections
strengthens associations between environmental stimuli and stressful events
(Mansvelder et al., 2009).
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rons in this area can affect metabolism. In nonhuman primates,
neurons in the substantia innominata and lateral hypothalamus
(LH), most of which express cholinergic markers, were activated
in response to presentation of food when the animals were
hungry (Rolls et al., 1979). Consistent with a potential role for
ACh in coordinating caloric need with food-seeking behaviors,
long-term maintenance on a high-fat/high-sugar diet signifi-
cantly downregulated levels of AChE in a number of brain areas
that was particularly pronounced in the hypothalamus (Kaizer
et al., 2004). One possibility is that the role of ACh in the hypo-
thalamus is to integrate the interoceptive cues related to hunger
with exteroceptive cues of food availability, threat, or other
salient conditions (Craig, 2002, 2003), but this remains to be
tested.
At the cellular level, stimulation of nAChRs and mAChRs on
LH neurons increases and decreases GABA release, respec-
tively (Jo and Role, 2002). The data suggest that nAChRs and
mAChRs may be localized to different populations of
GABAergic terminals, but from these studies, it is difficult to
determine what the effects of synaptically evoked ACh on LH
GABA release might be. Optogenetic stimulation of cholinergic
transmission in the LH and hypothalamus will be useful in
identifying the source of ACh input to these areas, the role of
intrinsic ACh in hypothalamic function, and the differential role
of mAChRs and nAChRs in shaping responses to ACh in these
brain regions. In the arcuate nucleus of the hypothalamus, nico-
tine increases the firing rate of both POMC- and neuropeptide Y
(NPY)-positive neurons, although the increase in POMC neuron
activity predominates in vitro due to more rapid desensitization
of nAChR responses in NPY neurons, and in vivo, as evidenced
by an increase in c-fos immunoreactivity predominantly in
POMC-positive cells (Huang et al., 2011; Mineur et al., 2011).
Thus, as in the mesolimbic system and the cortex, distinct
actions of ACh appear to converge through effects on receptor
populations with different electrophysiological properties ex-
pressed on distinct subsets of neurons to promote a coordinated
output, in this case, activation of POMC neurons.
ACh also regulates glutamatergic transmission in other neu-
ronal subtypes involved in food intake. Stimulation of nAChRs
on orexin-positive neurons in the LH induces concurrent release
of glutamate and ACh, which could lead to feed-forward stimu-
lation of this circuit once activated (Pasumarthi and Fadel,
2010). There is also some indication from studies of hypotha-
lamic neurons in culture that ACh signaling can be upregulated
to compensate for prolonged blockade of glutamatergic sig-
naling (Belousov et al., 2001). Thus, ACh acting through nAChRs
may also potentiate glutamate signaling in particular neuronal
subtypes of the hypothalamus, although the functional conse-
quences of this regulation are not yet known.
As might be expected from the complex regulation of hypo-
thalamic neuronal activity by ACh, cholinergic modulation of
feeding behavior is multifactorial and state-dependent. In rats,
the mAChR competitive antagonist atropine modestly altered
the frequency and choice of meals, but not their size (Nissen-
baum and Sclafani, 1988). Consistent with the ability of nicotine
in tobacco smoke to decrease body weight in humans and food
intake in rats (Grunberg et al., 1988), b4-containing nAChRs on122 Neuron 76, October 4, 2012 ª2012 Elsevier Inc.POMC neurons are critical for the ability of nicotine to reduce
food intake in mice (Mineur et al., 2011). These observations
underscore a potential role for ACh in metabolic regulation
involving POMC neurons; however, very little is known about
the role of endogenous ACh-mediated modulation of the arcuate
nucleus.
ACH and Stress-Related Systems
Increasing evidence suggests that ACh signaling in a number of
brain areas is important for stress responses (Figure 4). In addi-
tion to the well-documented role of the hippocampus in learning
and memory, the amygdala in mediating fear responses and the
prefrontal cortex (PFC) in attention, these brain areas are critical
nodes in adaptation and responses to stress (Belujon andGrace,
2011; Gozzi et al., 2010; McGaugh, 2004; Sapolsky, 2000; Tot-
tenham and Sheridan, 2009). Dysfunction in the activity of these
regions is strongly implicated in major depressive disorder
(Sheline et al., 1998; Videbech and Ravnkilde, 2004). The hippo-
campus, amygdala, and PFC receive a very high level of cholin-
ergic input that comes from the BF complex and, in particular,
from themedial septum and nucleus basalis, respectively (Mesu-
lam, 1995). Several studies have shown that stress increases
ACh release in a brain region-specific manner (Mark et al.,
1996). For instance, hippocampal and cortical ACh levels can
increase following restraint stress in rats, while ACh levels in
the amygdala are unchanged, although an increase in amygdalar
cholinergic tone can also reduce basolateral amygdala (BLA)
activity though activation of mAChRs (Power and Sah, 2008).
Conversely, acute activation of presynaptic a7 nAChRs in the
BLA can also favor the release of glutamate from impinging
cortical projections, which is critical for aversive memory and
Neuron
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development blunts paired facilitation due to subsequent
stimulation, however, which would be expected to decrease
BLA reactivity (Jiang and Role, 2008), further highlighting the
role of cholinergic signaling in plasticity of this system. The
hippocampus provides inhibitory feedback to the amygdala
through inhibition of the hypothalamic-pituitary-adrenal (HPA)
axis (Tasker and Herman, 2011). Interestingly, relief from stress
leads to an increase in cholinergic signaling in the amygdala
and PFC (Mark et al., 1996), indicating that the valence of ACh
varies by brain area. The effect of increased cortical ACh levels
on amygdala signaling has not been studied, but stress impairs
PFC output (Arnsten, 2009), and PFC can normally decrease ba-
solateral amygdala activity through projections to the interca-
lated nucleus (Manko et al., 2011; Pinard et al., 2012).
At the cellular level, neuronal activity in the hippocampus is
strongly modulated by both nAChRs and mAChRs. Cholinergic
inputs to the hippocampus from the medial septum and the
diagonal band of Broca impinge on both glutamatergic and
GABAergic neurons throughout the structure, and a comprehen-
sive review of the effects of ACh on synaptic plasticity in the
hippocampus has been published recently (Drever et al., 2011).
The ability of ACh to induce synaptic plasticity through actions
on pre- and postsynaptic nAChRs and mAChRs is likely to
modulate learning and memory, including memory of stressful
events (Nijholt et al., 2004), and a role for ACh in regulation of
hippocampal excitability through presynaptic release of gluta-
mate and GABA has also been well-characterized (Alkondon
et al., 1997; Freund et al., 1988; Radcliffe et al., 1999). Stress
also induces alternative splicing of the AChE messenger RNA
(mRNA) in the hippocampus, leading to altered ACh signaling
in this structure (Nijholt et al., 2004). There is currently no
consensus on how these cholinergic actions converge to regu-
late the output of the hippocampus in response to stress,
although one possibility is that ACh is critical for regulating
theta oscillations, and the concurrent effects of mAChRs and
nAChRs on excitatory and inhibitory transmission serve to regu-
late rhythmic activity (Drever et al., 2011; Fisahn et al., 1998).
Although theta rhythms are thought to be critical for memory en-
coding, disturbance of hippocampal rhythms may also con-
tribute to mood disorders (Femenı´a et al., 2012).
The amygdala also receives cholinergic inputs from the
basal forebrain complex (Mesulam, 1995) and is consistently
hyperactivated in fMRI studies of patients with mood disorders
(Drevets, 2001). In rodents, decreasing ACh signaling through
nAChRs depresses neuronal activity in the basolateral amyg-
dala, as measured by c-fos immunoreactivity (Mineur et al.,
2007). As discussed above, ACh shapes the output of cortical
neurons, and cortico-amygdala glutamatergic connections are
also strongly and persistently potentiated by nAChR stimulation
(Mansvelder et al., 2009). Thus, ACh release in the amygdala
is thought to strengthen associations between environmental
stimuli and stressful events, potentially contributing to maladap-
tive learning underlying affective disorders (Mansvelder et al.,
2009).
There is strong evidence that increasing ACh signaling in hu-
mans results in increased symptoms of depression (Janowsky
et al., 1972; Risch et al., 1980). This has been observed withadministration of the AChE blocker physostigmine to patients
with a history of depression, individuals with Tourette’s syn-
drome, and normal volunteers (Risch et al., 1980, 1981; Shytle
et al., 2000). A similar effect has also been described with organ-
ophosphate inhibitors of AChE (Rosenstock et al., 1991). More
recently, human imaging and post mortem studies have sug-
gested that there is increased occupancy of nAChRs by ACh
that is highest in individuals who are actively depressed and
intermediate in those who have a history of depression with no
change in overall nAChR number (Saricicek et al., 2012). In
rodent studies, the Flinders rat model was selected for its sensi-
tivity to challenge with an AChE inhibitor, and sensitive rats also
display a constellation of depression-like endophenotypes, sup-
porting the idea that increasing ACh levels increases symptoms
of depression (Overstreet, 1993).
Consistent with an increase in ACh leading to symptoms
of depression, antagonism of mAChRs or nAChRs or blockade
of ACh signaling through nAChRs with partial agonists can
decrease depression-like behavior in rodents (Caldarone et al.,
2004; De Pablo et al., 1991; Mineur et al., 2007; Picciotto et al.,
2002; Rabenstein et al., 2006). In humans, clinical trials have sug-
gested that blockade of either mAChRs (Furey and Drevets,
2006; Furey et al., 2010) or nAChRs (George et al., 2008; Shytle
et al., 2002) can decrease symptoms of depression. While an
increase in cholinergic tone appears to be sufficient to induce
depression-like symptoms in humans, a recent study has shown
that decreasing striatal cholinergic tone in the mouse can lead to
depression-like symptoms, likely through interneuron-depen-
dent disinhibition of striatal neurons (Warner-Schmidt et al.,
2012), highlighting the fact that ACh can induce heterogeneous
effects in different brain areas that appear to have opposite
behavioral consequences. The behavioral effect of ACh signaling
in vivo likely depends on the baseline conditions in the particular
circuit of interest at the time of ACh release and is the result of
integration of its sometimes conflicting effects in different
circuits. More studies are necessary to determine whether
preclinical studies of cholinergic signaling in hippocampus,
PFC, and/or amygdala can be linked to the effects of ACh in
human subjects and to identify physiological mechanisms that
are essential for these effects on behaviors related to mood
and affect.
Conclusions
A comprehensive explanation of cholinergic neuromodulation is
not yet possible, given the large number of behaviors, circuits,
neuronal subtypes, and cholinergic receptors in the brain.
Despite that complexity, some unifying themes have emerged.
The well-defined temporal association between firing of cholin-
ergic projection neurons in the brain stem and the pause in firing
of tonically active cholinergic interneurons in the striatum can
facilitate the association of salient rewarding events with cues
in the environment, contributing to reward prediction and pro-
moting orienting behaviors toward potentially rewarding stimuli.
This likely occurs through coordinated increases in glutamater-
gic drive that facilitate DA neuron burst firing and decreases
in response to subthreshold, tonic signals from DA terminals.
Similarly, salient signals that require focused attention for correct
performance of behavioral tasks increase feed-forwardNeuron 76, October 4, 2012 ª2012 Elsevier Inc. 123
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through specific classes of interneurons. The promotion of coor-
dinated firing of adjacent axons and the promotion of rhythmic
activity in structures, such as the hippocampus when ACh is
released and levels are high, may provide an increase in the
baseline excitability of neurons that are then available for robust
responses to glutamate, and this state dependent facilitation of
neurotransmission in pathways activated in response to ACh
release is likely to be maintained due to facilitated neuronal
plasticity. This organization is echoed in the hypothalamus,
where, despite the ubiquitous expression of nAChRs on multiple
neuronal subtypes with reciprocal functions, the kinetics of acti-
vation of one set of receptors may bias the output in one direc-
tion, based on the starting conditions. This is obviously a gross
oversimplification that will be sensitive to the timing, duration,
and localization of ACh signaling, but may provide a framework
for generation of hypotheses. Finally, increases in ACh signaling
appear to contribute to stress-related illnesses, such as major
depressive disorder, although the specific neuronal substrates
and cellular mechanisms responsible for these effects are only
beginning to be studied.
Despite a great deal of progress, there are still critical gaps in
our understanding of the dynamics of ACh release from different
neuronal populations; how that changes in response to environ-
mental conditions, such asmetabolic need or stress; and how far
from the site of release ACh can diffuse in different brain areas.
While novel tools will allow more precise stimulation of ACh
release, the patterns of release will not be optimal unless there
is a better understanding of the physiological patterns of firing.
The ability to mimic patterns of ACh release in vivo will be critical
for identifying the physiological effects of cholinergic neuromo-
dulation and distinguishing the actual from the possible effects
of ACh in the brain.
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